Aleksandra Jacobs
<p>Aleksandra Djukic, is Associate Professor of Neurology . She completed her neurology residency at the Albert Einstein College of Medicine. She is a diplomate of the American Board of Psychiatry and Neurology.</p>
<p>Dr. Djukic has Ph.D. in neuropsychology and is especially qualified for evaluations and treatment of children with learning disabilities, addressing both cognitive and neurological problems in children with a variety of hereditary neurological diseases and babies with neonatal neurological problems.</p>
<p>Dr. Djukic gained extensive experience following and treating more than 300 children with traumatic brain injuries.</p>
<p>Currently she is <strong>Director of the Center for Rett Syndrome</strong> which is the only Center for Rett syndrome in the Tri-State area.</p>
<p>Dr. Djukic is member of the International Consortium for Rett Syndrome "RettSearch", Leader of the Working group for development of Treatment Quidelines for Rett Syndrome, Grant reviewer for IRSF, member of the International Committee for the research of bio markers in Rett Syndrome and member of the International Committee for the research of the outcome measures in Rett Syndrome.</p>
<p>Dr. Djukic is member of RE-TT (Rett Education -Transforming Teaching) a group which is actively addressing educational issued and provides support to families .</p>
<p>Dr. Djukic is also Director of the Neonatal Neurology service.</p>
<p>She is a member of the New York State Consortium for Krabbe Disease .<br /><br />Dr. Djukic speaks both English and Serbian.</p>
Neuropsychology
The clinical focus is providing care for patients with Rett syndrome. She founded the Tri-State Rett Center at Montefiore in 2008, which provides comprehensive multidisciplinary care to 380 patients with Rett syndrome, and has been awarded a designation of the National Center of Excellence for Rett syndrome in 2021. Dr. Djukic serves on the Medical Advisory Board of the International Rett Syndrome Foundation. She has published about clinical care and worked with other Rett specialists to develop a better understanding of Rett syndrome and develop better outcome measures and biomarkers that can be used in treatment trials. She was the founder of an international Blue Sky Girls event that raised awareness about Rett syndrome.
Her vision to develop the Rett Syndrome Center at Montefiore originated from the optimism brought by the scientific evidence that several major aspects of the phenotype of the disorder could be fully reversed in an animal model, even in its terminal stages. However, we still do not understand well the full phenotype of the human disease inter-relationship between various symptoms, especially those autonomic and behavioral/cognitive. The main research goals of the Rett Syndrome Center, therefore, entail systematic and uniform documentation of the natural history, development of objective outcome measures, and better treatment strategies. These goals complement our endeavor to implement the best clinical practices in the clinical care of our patients.<br /><br />Dr. Djukic has a special interest in neuropsychology and how those with Rett syndrome communicate and excel in their education. She was the first to implement effective eye tracking technology as a method of cognitive assessment in patients with Rett syndrome and objective neurophysiological techniques to assess their language processing. <br /><br />Her current main research interest is related to the development of more effective therapies for individuals with Rett syndrome. She was the Principal investigator in seven clinical trials of Rett syndrome. She has also published about clinical care and worked with other scientists to develop a better understanding of Rett syndrome and develop better outcome measures and biomarkers that can be used in treatment trials.
<p>Djukic, A., Lado, F. A., Shinnar, S., Moshé, S. L., Are early myoclonic encephalopathy (EME) and the Ohtahara Syndrome (EIEE) independent of each other? Epilepsy Research, 70 (2-3S): 68-76 (2006).</p>
<p>Djukic A. Folate responsive neurological disorders, in Press. Pediatric neurology 2007. Review.</p>
<p>Wilson S, Djukic A, Shinnar S, Dharmani C, Rapin I. (2003) Clinical characteristics of language regression in children. Developmental Medicine Child Neurology 45:508-514.</p>
<p style="text-autospace: none; font-family: 'Times New Roman'; font-size: 12.0pt; margin: 0in 0in .0001pt 0in;"><span style="font-family: Arial; font-size: 11.0pt;">Djukic A.</span><span style="font-family: Arial; font-size: 10.0pt;"> Neurological Abnormalities in newborn , AAP ,Pediatric Primary Care , Chapter 106</span></p>
<p style="text-autospace: none; font-family: 'Times New Roman'; font-size: 12.0pt; margin: 0in 0in .0001pt 0in;"> </p>
<p style="text-autospace: none; font-family: 'Times New Roman'; font-size: 12.0pt; margin: 0in 0in .0001pt 0in;"><span style="font-family: Arial; font-size: 10.0pt;">Djukic A, Vigevano F, Plouin P, Moshe S.L. Early myoclonic encephalopathy (neonatal myoclonic encephalopathy)</span><span style="font-family: 'Times New Roman'; font-size: 11.0pt; color: black;">. Epilepsy: a comprehensive textbook, 2 ed. Engel J, Pedley T eds. Lippincot Williams&Wilkins, Philadelphia 2007. Chapter 224.</span></p>